The Pass Machine Pulmonary Disease Board Review v 5.1 2021

90 $

+ Include:  videos +  pdf, size:  GB

+ Target Audience: pulmonary physician

Description

+ Include:  videos +  pdf, size:  GB

+ Target Audience: pulmonary physician

+ Sample video: contact me for sample video

+ Information:

Online Course v5.1
Videos in interactive way

Question bank in PDF format

Intended Audience: Pulmonologists

Learning Objectives:
Upon completion of this program, participants should be able to:

  • Classify types of pulmonary neoplasia
  • Assess pulmonary infections and treatment guidelines respective to the infection
  • Differentiate respiratory and non-respiratory sleep disorders
  • Explain pulmonary critical care including chest trauma, mechanical ventilation, pharmacotherapy, and respiratory failure
  • Develop comprehensive management and treatment plans for patients with COPD
  • Describe the variations of Asthma and corresponding causes in determining treatment
Obstructive Lung Disease
Asthma: Overview & Treatment (1 Hour)
Raj Dasgupta, MD
Asthma: Special Circumstances (0.5 Hours)
Raj Dasgupta, MD
COPD (1 Hour)
Raj Dasgupta, MD
Obstructive Airway Disease (1 Hour)
Jonathan Puchalski, MD, MEd
Critical Care Medicine
Lung: Acute Respiratory Distress Syndrome (ARDS) (1.5 Hours)
Urvashi Vaid, MD, MS
Lung: Weaning & Non-Invasive Positive Pressure Ventilation (0.25 Hours)
Jonathan Puchalski, MD, MEd
Lung: Ventilator Modes & Respiratory Mechanics (0.75 Hours)
Jonathan Puchalski, MD, MEd
LNon-Lung (1 Hour)
Jonathan Puchalski, MD, MEd
Sleep Medicine/Neuromuscular/Skeletal
Respiratory (1 Hour)
Shirin Shafazand, MD
Non-Respiratory – Physiology, Polysomnography & Insomnia (1 Hour)
Raj Dasgupta, MD
Non-Respiratory – Hypersomnia, Circadian Disorders & Parasomnias (1 Hour)
Raj Dasgupta, MD
Congenital, Neuromuscular & Skeletal (1 Hour)
Jonathan Puchalski, MD, MEd
Diffuse Parenchymal Lung Disease
Restrictive Lung Disease – Basics of Physiology & Classification (0.75 Hours)
Shirin Shafazand, MD
An Approach to Diagnosis of Interstitial Lung Disease (1 Hour)
Shirin Shafazand, MD
Idiopathic Pulmonary Fibrosis (0.75 Hours)
Shirin Shafazand, MD
Occupational & Environmental Disease (1.5 Hours)
Jonathan Puchalski, MD, MEd
Infections
Sepsis (1.25 Hours)
Robert A. Balk, MD
Abscess, Emboli & Pneumonias (1.25 Hours)
Robert A. Balk, MD
Fungal & Mycobacterial Disease (1 Hour)
Jonathan Puchalski, MD, MEd
Opportunistic Pathogens & Bronchiolar Disease (1.25 Hours)
Fayez Kheir, MD
Neoplasms
Diagnosis, Evaluation & Tumor Pathology (1.5 Hours)
Douglas A. Arenberg, MD
Epidemiology, Treatment & Syndromes (1.25 Hours)
Douglas A. Arenberg, MD
Basic Science and Physiology
Cell & Molecular Biology (1 Hour)
Douglas A. Arenberg, MD
Physiology & Metabolism (1 Hour)
Jonathan Puchalski, MD, MEd
Quality, Safety, and Ethics
Quality, Safety & Complications (1 Hour)
Jonathan Puchalski, MD, MEd
Ethics (0.5 Hours)
Jonathan Puchalski, MD, MEd
Pleural Disease
Pleural Disease (1 Hour)
Jonathan Puchalski, MD, MEd
Epidemiology and Statistics
Epidemiology & Statistics (1 Hour)
Shirin Shafazand, MD
Vascular Disease
Pulmonary Vascular Diseases (1 Hour)
Shirin Shafazand, MD
Thromboembolic Disease (1 Hour)
Shirin Shafazand, MD
Transplantation
Transplantation (1 Hour)
Shirin Shafazand, MD

 

+ Topics:

 

Reviews

There are no reviews yet.

Be the first to review “The Pass Machine Pulmonary Disease Board Review v 5.1 2021”

Your email address will not be published. Required fields are marked *